Last updated on February 2018

CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma


Brief description of study

The purpose of this study is to evaluate the safety and effectiveness of CAR-pNK cell immunotherapy in patients with CD7 positive relapsed or refractory Leukemia and Lymphoma.

Clinical Study Identifier: NCT02742727

Find a site near you

Start Over